Pembrolizumab 83012-0010
Product NDC
83012-0010- Manufacturer
- Boehringer Ingelheim Fremont, Inc.
- Dosage Form
- Liquid
- Product Type
- Bulk Ingredient
- Marketing Start
- April 26, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pembrolizumab | 25 mg/25mg |
Packaging Options(1)
25 mg in 1 BAG (83012-010-99)